🇺🇸 FDA
Patent

US 8633177

Nitroxyl (HNO) releasing compounds and uses thereof in treating diseases

granted A61PA61P25/32A61P29/00

Quick answer

US patent 8633177 (Nitroxyl (HNO) releasing compounds and uses thereof in treating diseases) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61P, A61P25/32, A61P29/00, A61P35/00, A61P7/02